期刊文献+

基质金属蛋白酶在脑血管疾病中的研究进展 被引量:8

Research progress of matrix metalloproteinases in cerebrovascular diseases
下载PDF
导出
摘要 脑血管疾病如颅内动脉粥样硬化、颅内动脉瘤、缺血性脑卒中等已成为人类致死、致残的重要原因,在多种致病因素共同作用下脑血管结构和功能改变是脑血管疾病共同的病理生理基础。目前,脑血管疾病的病因尚未得到阐明,有越来越多的证据表明基质金属蛋白酶在其发生、发展中发挥重要作用,阻断或抑制基质金属蛋白酶的表达为脑血管疾病的无创治疗提供了新理论依据。本文综述基质金属蛋白酶与脑血管疾病的相关关系。 Cerebrovascular diseases such as intracranial atherosclerosis,intracranial aneurysm and ischemic stroke have become the important causes of death and disability.The structural and functional changes of cerebrovascular,which are caused by various pathogenic factors,are the common pathophysiological basis of cerebrovascular diseases.At present,the etiology of cerebrovascular diseases has not been clarified.Growing evidence suggests that matrix metalloproteinases play an important role in the occurrence and development of cerebrovascular diseases.Blocking or inhibiting the expression of matrix metalloproteinases provides a new theoretical basis for non-invasive treatment of cerebrovascular diseases.This review discusses the relationship between matrix metalloproteinases and cerebrovascular diseases.
作者 唐海双 骆银 左乔 张洪剑 黄清海 刘建民 TANG Hai-shuang;LUO Yin;ZUO Qiao;ZHANG Hong-jian;HUANG Qing-hai;LIU Jian-min(Department of Neurosurgery,Changhai Hospital,Naval Medical University(Second Military Medical University),Shanghai 200433,China)
出处 《第二军医大学学报》 CAS CSCD 北大核心 2020年第8期876-879,共4页 Academic Journal of Second Military Medical University
基金 国家重点研发计划重大慢性非传染性疾病防控重点专项资助项目(2016YFC1300703) 国家自然科学基金(81701136)。
关键词 基质金属蛋白酶类 脑血管障碍 动脉粥样硬化 颅内动脉瘤 卒中 matrix metalloproteinases cerebrovascular disorders atherosclerosis intracranial aneurysm stroke
  • 相关文献

参考文献2

二级参考文献27

  • 1Strbian D, Durukan A,Pitkonen M, Marinkovic l,Tatlisun, ak E, Pedrono E, et al. The blood brain barrier is continuously open for several weeks following transient focal cerebral ische mia[J].Neuroscience,2008,153:175- 181.
  • 2Strloian D, Karjalainen Lindsbera M L, Kovanen P T, Tadisu mak T,Lindsberg P J. Mast cell stabilization reduces hemor rhage formation and mortality after administration of thrombo lyrics in experimental ischemic stroke[J]. Circulation, 2007. 1l6:411-418.
  • 3Wang X,Lee S R,Arai K,I.ee S R,Tsuji K,Rebeck G W,et al. Lipoprotein receptor mediated induction of malrix metallopro teinase by tissue plasminogen activator[J]. Nal Med,2003,9: 1313- 1317.
  • 4Hamann G F,Okada Y,Fitridge R,del Zoppo G J. Microvascular basal lamina antigens disappear during cerebral ischernia and reperfusion[J]. Slroke, 1995,26:2120- 2126.
  • 5Yang Y,Estrada E Y,Thompson J F,Liu W,Rosenberg G A. Matrix metalloproteinase mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat[J]. J Cereb Blood Flow Metab,2007 ,27 :697- 709.
  • 6Nagel S,Su Y, Horstmann S,Heiland S,Gardner H,Koziol J,et al. Minncycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acule and subacutc phase[J].Brain Res,2008,1188:198- 206.
  • 7Longa E Z,Weinstein P R,Carlson S,Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats [J].Stroke,1989,20:84 -91.
  • 8del Zoppo G J, Milner R, Mabuchi T, Hung S, Wang X, Berg GI,et al. Microglial activation and matrix protease generation during focal cerebral ischemia [J]. Stroke,2007,38:646- 651.
  • 9Asahi M,Wang X,Mori T,Sumii T,Jung J C,Moskowitz M A, et al. Effects of matrix metalloproteinase-9 gene knock out on the proteolysis of blood-brain barrier and white matter compo nents after cerebral ischemia [J]. J Neurosci, 2001, 21: 7724- 7732.
  • 10Rosenberg G A,Estrada E Y,Dencoff J E. Matrix metalloproteinases and T1MPs are associated with blood brain barrier o pening after reperfusion in rat brain [J].Stroke,1998,29:2189- 2195.

共引文献17

同被引文献55

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部